Wound Healing:
Join the Revolution

Innovative RecoSMA Laser Technology for Septic & Chronic Wound Treatment
View a brief video showcasing the
RecoSMA technology
Wound Healing

Why LINLINE Provides the Best Solution for Non-Healing Chronic Wounds

LINLINE’s RecoSMA laser technology offers a breakthrough approach to chronic wound healing by combining laser wound debridement and laser-induced tissue regeneration.
Regenerative technology; induces neo-angiogenesis
Regenerative technology; induces neo-angiogenesis
Fast and gentle wound bed cleaning, safe for viable tissues
Fast and gentle wound bed cleaning, safe for viable tissues
Pain-free treatment is comfortable for patients
Pain-free treatment is comfortable for patients
Significantly reduces the time of healing as compared to conventional methods
Significantly reduces the time of healing as compared to conventional methods
No antibiotics or antiseptics as pathogenic flora is eliminated by laser
No antibiotics or antiseptics as pathogenic flora is eliminated by laser
Mono-method; no need for any other treatments or special dressing
Mono-method; no need for any other treatments or special dressing
The total cost with RecoSMA is grossly less than hospitalisation
The total cost with RecoSMA is grossly less than hospitalisation
Wound Healing by Tissue Proliferation not by Contraction!
Wound Healing by Tissue Proliferation not by Contraction!

Two-Step Treatment Approach

for septic and chronic wounds treatment
Wound Debridement
by High-Energy Erbium Laser
  • Eliminates bacteria
  • Removes necrotic detritus
  • Constructs a healthy wound bed
  • Doesn't affect viable tissues
  • Easy visually-controlled
Reparative Regeneration Stimulation with RecoSMA — the patented
technology of LINLINE
  • Enhances trophism
  • Stimulates neoangiogenesis
  • Triggers rapid tissue growth
  • Repairs functional tissues
  • Remodels without scarring
Step#1
Step#2
Debridement plays a vital role in wound bed preparation, removing barriers that impair wound healing
How does the Erbium laser work?
The pulsed Er:YAG laser emits light with a wavelength of 2940 nm corresponding to the water absorption peak. Because 90% of the soft tissue is water, most of the laser energy is superficially absorbed.
Each pass of the erbium heats tissue to over 300°C. As a result, the water in the tissue is rapidly expanded to eject the charred debris from the wound surface without leaving behind a necrotic eschar.
What is essential, viable tissues remain safe since their high content of water (blood in capillaries) acts as a natural barrier to the Erbium laser radiation - all the energy absorbs in a very superficial area.
Advantages of Erbium laser
  • Precision and uniformity
  • Painless treatment
  • Zero risk for viable tissue
  • Done as frequently as needed
  • Fast and easy to perform
  • Low operating costs
  • No special dressing required
RecoSMA treatment triggers a response that enhances microcirculation, metabolism, and tissue trophism, thereby promoting tissue repair

Clinical cases

Female, 55, diabetic, hypertension and gout, non-healing foot ulcer.
10 laser sessions
View a brief video showcasing the
RecoSMA technology

Clinical cases

Male, 56. Fourth-degree frostbite of the fingers. 8 laser sessions.
Complete soft tissue recovery.

Clinical cases

Male, 60. Non-healing burn wound for over 2 months. 2 laser sessions.
Complete epithelialization with no scarring or contractures.

Clinical cases

A 48-year-old female patient diagnosed with a right plantar hindfoot ulcer. Duration: 3 weeks.
Initial area: 42 cm2. Sessions: 6. Time to wound closure: 7 weeks. Follow up: 62 months

Clinical cases

A 76-year-old female patient diagnosed with a right leg lower-third ulcer. Duration: 60 weeks. Initial area: 108 cm2. Sessions: 8. Time to wound closure: 9 weeks. Follow up: 14 months.

Clinical cases

A 71-year-old male patient diagnosed with a right leg lower-third ulcer.
Duration: 68 weeks. Initial area: 36 cm². Sessions: 6. Time to wound closure: 7 weeks. Follow up: 5 months.

Clinical cases

A 70-year-old male patient diagnosed with a right diabetic foot ulcer on dorsum with tendon exposed.
Duration: 8 weeks. Initial area: 60 cm². Sessions: 8. Time to wound closure: 9 weeks. Follow up: 6 months

Clinical cases

Female 16. Decubitus Ulcer in the Upper Third of the Posterior Surface of the Thigh.

Clinical cases

Female, 5 months. Progressive Hemangioma in Gluteal Region alongside Ulceration and Tissue Necrosis

Clinical cases

Female, 58. Trophic Ulcers, Vasculitis. 14 sessions.

Clinical cases

Female, 31. Non-healing wound due to suture dehiscence after mastopexy.
5 laser sessions.

Clinical cases

F, 33, Wound dehiscence after plastic surgery. 2 sessions.

Clinical cases

F, 58, Trophic ulcers, vasculitis. 14 sessions.

Clinical cases

F,67, Venous leg ulcer, type 2 diabetes. 14 sessions.

Clinical cases

F, 5 months, Ulcerated Infantile hemangioma. 11 sessions.

Clinical cases

M, 37, Diabetic ulcer. 8 sessions.

Clinical cases

Female, 31. Chronic post-traumatic neurotrophic foot ulcer
(approx. 5 years duration). 10 laser sessions.

Clinical cases

Male, 45. Non-healing wound of the anterior abdominal wall following
hepatectomy and relaparotomy, complicated by a postoperative
Pseudomonas aeruginosa infection. 9 laser sessions.

Clinical cases

M, 36, Trophic ulcer, chronic osteomyelitis. 5 sessions.

Clinical cases

Female, 28. Non-healing leg ulcer due to Budd-Chiari syndrome,
complicated by severe lower limb edema and the development
of bullous-necrotic erysipelas. 4 laser sessions.

Clinical cases

M, 65, Long-term non-healing sternal wound (coronary bypass surgery). 8 sessions.

Testimonials

University Medical Centre Ljubljana
Assoc. Prof. Igor Frangez, MD/MDS, PhD, EAFWH Head of Department for Surgical Infections www.kcl.si
Ljubljana University Hospital has conducted a clinical trial of the LINLINE treatment methods (Erbium laser debridement and RecoSMA) for wounds that have not responded to standard care. The results from treating a diverse group of patients with non-healing wounds—including venous, diabetic, and post-burn ulcers—demonstrated the effectiveness of this approach. Notable advantages include: method's simplicity, rapid treatment process, absence of consumables.
Shaare Zedek Medical Center, Jerusalem
Ilya Goldin, MD, Head of Vascular Surgery Unit, Shaare Zedek Medical Center, erusalem, Israel www.szmc.org.il
The introduction of the LINLINE Multiline laser platform (Linline Medical Systems, Riga, Latvia) in our Vascular Surgery Department has provided a promising approach to treating long-standing, non-healing wounds. The ability to perform wound debridement without anesthesia, combined with stimulation, allows for the conversion of chronic wounds to an acute phase, which may accelerate healing.
Hospital Kuala Lumpur, Malaysia
Dr. Harikrishna K.R. Nair, DMU, S.I.S, KMN, Head of Wound Care Unit, Hospital, Kuala Lumpur www.hkl.moh.gov.my/en
In a recent clinical study involving patients with non-healing wounds—including diabetic foot ulcers, venous ulcers, traumatic wounds, and post-operative wounds, the Erbium-YAG laser from LINLINE Medical Systems delivered highly positive results.
Key Benefits: promotes revascularization and collagen synthesis; minimizes chronic pain; enhances tissue repair; ensures complete wound sanitation.
Henri Mondor Hospital, France
Prof. Jean-Paul MENINGAUD, MD, PhD, Head of the Dept. of Plastic and Maxillofacial Surgery www.chu-mondor.aphp.fr
I am writing to recommend the RecoSMA laser technology developed by LINLINE Medical Systems, which has been extensively utilized and validated at the Department of Plastic and Reconstructive Surgery at Henri Mondor Hospital. I highly recommend RecoSMA technology to enhance clinical offerings and improve patient outcomes.
European Laser Association
Dr. Mario A. Trelles, plastic aesthetic and reconstructive surgeon, president of the European Laser Association (ELA)
The European Laser Association (ELA) oversees the use of lasers in medical treatments and closely follows the innovative work of LINLINE Medical Systems in developing Er:YAG laser technology, particularly RecoSMA methodology for chronic lower extremity ulcers (CLEUs).

Key Scientific Findings:
  • RecoSMA technology stimulates tissue regeneration and accelerates wound healing.
  • Reduces pain during treatment, making it an alternative to sharp debridement methods.
  • Promotes collagen remodeling, enhancing wound healing.
Gleneagles Hospital, Mumbai
Dr. Nilesh G. Satbhai — M.S, M.Ch (Plastic Surgery), Consultant Plastic, Aesthetic, Hand & Reconstructive Microsurgeon www.gleneagleshospitals.co.in
I have been using the RecoSMA laser platform from LINLINE over the last 2 years. And I can wholeheartedly accept that it has made a huge difference to my practice and to my clinical outcomes. It is one and only laser which has shown remarkable effect on wound healing. I have noticed a significant reduction in the healing time of wounds with the laser treatment. I have also used the laser in several unusual situations including intra-operatively, with excellent results.
Dr. Monira NOU-HOWALDT
Vascular Surgeon, Montpellier University Hospital
The management of chronic leg ulcers that do not respond to standard treatments is a real challenge in terms of public health due to the significant costs generated and considerably alters the quality of life of patients. The YAG/Er RecoSMA Laser is a very promising solution in this indication because it allows the biofilm to be effectively removed thanks to the effect of the laser ablation and its mechanical-acoustic effect promotes cell regeneration. Combined with the usual treatments for leg ulcers, it can restart the healing of ulcers that are difficult to heal.
Dr. Ram Mahadev Chilgar
Board-certified plastic surgeon, holds an MCh in Plastic Surgery, Fellowship in Cosmetic Surgery, and Microsurgery from Taiwan. Director at Elrevo Clinic.
RecoSMA technology, which utilizes the precision and power of the laser, has shown remarkable success in treating hard-to-heal diabetic ulcers.
In our study involving 59 patients, published in 2023 in the Journal of Wound Care (UK), we observed a significant reduction in the average number of sessions required for wound closure. The mean wound surface area at baseline was 25.7 cm², and the average number of sessions required was just 4.41, ranging from 1 to 11 sessions.
What sets RecoSMA apart is its ability to treat the wound surface and deeper tissues simultaneously, promoting faster and more effective healing. This technology not only aids in debridement but also stimulates the body's natural healing processes, enhancing revascularisation and supporting collagen synthesis. The result is a more natural and robust healing process, significantly reducing the risk of recurrence. The procedure is minimally invasive, can be performed on an outpatient basis, and is well-tolerated by patients.
Dr Dhirendrakumar Patil
MBBS, MS-General Surgery, Mch - Plastic Surgery, Diabetic Foot Surgeon. Amrut Wound Clinic, Mumbai
RecoSMA laser is regenerative Laser. I have documented regeneration of planter skin. Wound 5 cm X 3.5 cm on heal will not heal by wound contraction. Obviously it is possible only by tissue proliferation. How this will happen? Regeneration of different tissue by stimulation of stem cells. If this laser is stimulating epithelial stem cells then it should stimulate other stem cells also. That is how I started work on Hair regrowth. In female patients results are promising. This not only controls & stops hair fall but also shows improvement in texture of hairs leading to fullness. Hair regrowth in male patients are convincing & promising. Other problems besides non healing wounds where RecoSMA laser is very useful are Elimination of scars, Keloid, Hypertrophic scars & stretch mark.
Dr Vasant Gholave
MBBS,MS,M.Ch.in plastic & Reconstructive surgery
Arra Aesthetics, Pune
Amazing laser technology. Patients suffering from chronic wounds do dressings for months. The RecoSMA laser technology for wound healing can be considered a near miracle. The problem with laser wound healing is that heat is detrimental to wounds, but LINLINE has achieved the perfect balance in the amount of Laser heat which stimulates wound healing. This low photothermal effect is the precise reason why RecoSMA laser treatment works in two of the most challenging treatment scenarios: chronic wounds and Keloids. My patients are getting immensely benefiting from RecoSMA laser treatment . Thanks

Contact us

LINLINE MEDICAL SYSTEMS SIA
Krasta iela 105A/LV — 1019 Riga, Latvia +371 22 45 3227